Literature DB >> 22711682

Histopathologic assessment of pancreatic cancer: does one size fit all?

Michelle D Reid1, Pelin Bagci, N Volkan Adsay.   

Abstract

Most solid pancreatic tumors are invasive ductal adenocarcinoma (PDAC). Because PDAC is the most common tumor, it has become synonymous with the term "Pancreas Cancer." However, other malignant neoplasms occur in the pancreas (acinar, neuroendocrine and colloid carcinomas, and metastases) all with different outcomes. Because these tumors are often combined with PDAC in research databases, it causes misleading variability in the analysis of pancreatic cancers. We examine the histopathology of a variety of pancreatic cancers.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh：

Year:  2012        PMID： 22711682     DOI： 10.1002/jso.23194

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  9 in total

1.  [Update of the S3 guidelines for pancreatic cancer. What is new for pathologists?].

Authors:  J Munding; J Lüttges; I Esposito; A Tannapfel
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

2.  Colloid (mucinous non-cystic) carcinoma of the pancreas: A case report.

Authors:  Yang Gao; Ya-Yun Zhu; Zhou Yuan
Journal:  Oncol Lett       Date:  2015-09-21       Impact factor: 2.967

3.  Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer.

Authors:  Miguel A Ortega; Oscar Fraile-Martinez; Leonel Pekarek; Cielo García-Montero; Miguel Angel Alvarez-Mon; Alejandro J Castellanos; Natalio García-Honduvilla; Julia Buján; Melchor Alvarez-Mon; Miguel A Sáez; Luis G Guijarro; Angel Asúnsolo
Journal:  Antioxidants (Basel)       Date:  2022-04-11

4.  Reduced expression of caspase-8 and cleaved caspase-3 in pancreatic ductal adenocarcinoma cells.

Authors:  Katarzyna Jakubowska; Katarzyna Guzińska-Ustymowicz; Waldemar Famulski; Dariusz Cepowicz; Dorota Jagodzińska; Anna Pryczynicz
Journal:  Oncol Lett       Date:  2016-01-19       Impact factor: 2.967

Review 5.  Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors.

Authors:  Gabriela Reyes-Castellanos; Nadine Abdel Hadi; Alice Carrier
Journal:  Cells       Date:  2022-01-26       Impact factor: 6.600

6.  The anti-tumor effect of HDAC inhibition in a human pancreas cancer model is significantly improved by the simultaneous inhibition of cyclooxygenase 2.

Authors:  Olivier Peulen; Arnaud Gonzalez; Paul Peixoto; Andrei Turtoi; Denis Mottet; Philippe Delvenne; Vincent Castronovo
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

7.  Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.

Authors:  Yang Gao; Yayun Zhu; Zhenzhen Zhang; Cheng Zhang; Xinyu Huang; Zhou Yuan
Journal:  J Exp Clin Cancer Res       Date:  2016-04-12

8.  p53 and p16Ink4a/p19Arf Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells.

Authors:  Stephanie Azzopardi; Sharon Pang; David S Klimstra; Yi-Chieh Nancy Du
Journal:  Neoplasia       Date:  2016-09-21       Impact factor: 5.715

9.  Clinical Analysis of Acinar Cell Carcinoma of the Pancreas: A Single-Center Experience of 45 Consecutive Cases.

Authors:  Wentao Zhou; Xu Han; Yuan Fang; Siyang Han; Yumeng Cai; Tiantao Kuang; Wenhui Lou; Dansong Wang
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.